Granules Pharmaceuticals Inc.

Form 483 issued January 17, 2020 · Chantilly, Virginia

Investigator
Sena G. Dissmeyer
Observations
3
Pages
3
FEI number
3011585184

In short: On January 17, 2020, FDA issued a Form 483 with 3 observations to Granules Pharmaceuticals Inc. in Chantilly, Virginia (FEI 3011585184). The investigator was Sena G. Dissmeyer. Most observations concern production and facilities & equipment.

At a glance

2 of 3 observations on this 483 concern production.

Production2
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…

  2. 02

    There are no written procedures for production and process controls designed to assure that the drug…

  3. 03

    Master production and control records lack complete manufacturing and control instructions and…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Granules Pharmaceuticals Inc.?

FDA listed 3 observations on this Form 483, mostly about production and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Granules Pharmaceuticals Inc.?

Sena G. Dissmeyer is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Granules Pharmaceuticals Inc. inspected by FDA?

This Form 483 is dated January 17, 2020.

How do I get the full Form 483 for Granules Pharmaceuticals Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free